Makka (Corn)

Zea mays
Makka (Corn), a widely cultivated cereal, is acknowledged in Ayurveda, though its direct traditional use might be less emphasized than other grains. It's supposedly beneficial for increasing Kapha and Vata doshas, making it a warming and building food. While prevalent globally as a staple, its specific role in Ayurvedic formulations is less common, primarily recognized for its nutritive value.
PLANT FAMILY
Poaceae (Grass)
PARTS USED
Whole plant, Kernels
AYURVEDIC ACTION
Vata ↑, Kapha ↑
ACTIVE COMPOUNDS
Zeaxanthin, Lutein

What is Makka (Corn)?

Makka, commonly known as corn (Zea mays), is a widely cultivated cereal grain belonging to the grass family Poaceae. Originating in Mesoamerica, it is one of the world's most important staple crops, providing sustenance for humans and livestock alike. The plant typically features a tall, sturdy stalk with large, broad leaves and produces ears composed of numerous kernels arranged in rows.

These kernels, which are technically fruits, are the primary edible part, renowned for their versatility. They can be consumed fresh, dried, ground into flour, or processed into various food products like cornstarch and corn syrup. Beyond its culinary uses, corn also plays a significant role in industrial applications, including the production of biofuels and biodegradable plastics.

Other Names of Makka (Corn)

  • Maize
  • Indian Corn
  • Sweet Corn
  • Corn on the Cob
Corn in regional NSW, Australia, 2022

Benefits of Makka (Corn)

Heading

<h3> Absolute Contraindications of Makka (Corn) </h3> <h4> Severe maize (corn) allergy - (person has past immediate allergic reactions to corn) </h4> <ul> <li> 🔴 <li> Recommendation: Avoid all maize and maize-derived foods completely; carry epinephrine if prescribed and follow your allergist’s plan. <li> Reasoning: IgE-mediated maize allergy can produce systemic reactions including anaphylaxis at small doses; avoidance is the only safe option for those with confirmed clinical allergy. <li> Scientific_Study_Title: Maize food allergy: a double-blind placebo-controlled study <li> Scientific_Study_Authors: J Scibilia, E A Pastorello, G Zisa, A Ottolenghi, B Ballmer-Weber, V Pravettoni, E Scovena, A Robino, C Ortolani <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/18778272/ <li> Scientific_Study_Excerpt: <p>This multicentre double-blind, placebo-controlled study evaluated 27 patients with suspected maize allergy using skin tests, specific IgE measurement and controlled food challenges. Almost half (48%) of recruited subjects had positive challenges. Provocation doses among positives ranged from 0.1 g to 25 g of maize; some subjects reacted to as little as 100 mg. Nearly one quarter of positive cases had multi-system involvement meeting criteria for maize-induced anaphylaxis. The authors conclude maize is a documented cause of IgE-mediated food allergy and can trigger severe systemic reactions at low doses in sensitised individuals.</p> </ul> <h4> Pregnancy with high-risk exposure to fumonisin-contaminated maize - (pregnant person in region/setting where maize storage/contamination risk is high) </h4> <ul> <li> 🤰 <li> Recommendation: In pregnancy avoid consumption of maize that may be contaminated (poor storage, visibly mouldy, or from regions with known contamination); choose reliably tested/regulated grains and ensure periconceptional folic acid supplementation as advised by healthcare provider. <li> Reasoning: Fumonisin contamination of maize has been linked epidemiologically and experimentally to increased risk of neural tube defects; minimizing exposure during early pregnancy reduces risk. <li> Scientific_Study_Title: Maternal fumonisin exposure as a risk factor for neural tube defects <li> Scientific_Study_Authors: J Gelineau-van Waes, K A Voss, V L Stevens, M C Speer, R T Riley <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/19389609/ <li> Scientific_Study_Excerpt: <p>Fumonisins are mycotoxins produced by Fusarium species commonly contaminating maize. This review synthesizes epidemiologic and experimental data linking maternal fumonisin exposure with neural tube defects (NTDs). Mechanistically, fumonisin B1 inhibits ceramide synthase, which perturbs sphingolipid metabolism and can impair folate-receptor function; both pathways are important for neural tube closure. Human observational data from high-maize-consumption populations show associations between higher maize/tortilla intake and increased odds of NTDs; animal studies demonstrate teratogenic effects prevented in part by folate supplementation. The authors recommend reducing mycotoxin exposure and improving maternal folate status.</p> </ul> <h4> Chronic high intake of poorly stored/contaminated maize in regions with endemic aflatoxin/fumonisin exposure - (long-term heavy consumption of contaminated maize) </h4> <ul> <li> ⚠️ <li> Recommendation: Avoid long-term reliance on poorly stored or untested maize as a dietary staple; where exposure risk is present, use regulated food sources, and public health measures to reduce mycotoxin contamination should be pursued. <li> Reasoning: Chronic ingestion of aflatoxin- or fumonisin-contaminated maize is linked to increased risks of primary liver cancer and other serious toxicities; this is a population-level food safety contraindication rather than a personal food allergy. <li> Scientific_Study_Title: Aflatoxins as a cause of hepatocellular carcinoma <li> Scientific_Study_Authors: Michael C Kew <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24078988/ <li> Scientific_Study_Excerpt: <p>Aflatoxins produced by Aspergillus species frequently contaminate maize and are established human carcinogens associated with hepatocellular carcinoma (HCC) in high-exposure regions. The review outlines how aflatoxin B1 is metabolized by cytochrome P450 enzymes to a DNA-reactive epoxide that forms mutagenic adducts, including a characteristic p53 mutation, promoting hepatocarcinogenesis. Epidemiologic studies and biomarker data link lifetime dietary exposure to increased HCC risk, particularly where hepatitis B virus co-infection exists. The study emphasizes food storage and regulatory measures to lower exposure as key preventive strategies.</p> </ul> <h3> Relative Contraindications of Makka (Corn) </h3> <h4> Diabetes mellitus or impaired glucose tolerance (depending on corn form and processing) </h4> <ul> <li> 🩸 <li> Recommendation: Prefer whole/less-processed maize and maize products with higher fiber or resistant starch (or maize formulations using soluble corn fiber); monitor blood glucose and adjust medications with provider guidance. <li> Reasoning: Processed maize products (e.g., cornflakes) digest rapidly and have higher glycemic indices, increasing post-meal glucose; conversely, maize-derived fibers and resistant starches blunt postprandial glucose. The net effect depends on product form and preparation. <li> Scientific_Study_Title: Effect of novel maize-based dietary fibers on postprandial glycemia and insulinemia <li> Scientific_Study_Authors: (Study authors listed on PubMed entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/19155430/ <li> Scientific_Study_Excerpt: <p>In a randomized clinical feeding study, several maize-based fiber ingredients were tested in healthy volunteers. All maize fiber test ingredients produced significantly lower postprandial glycemic and insulinemic responses (iAUC over 2 hours) compared with the control carbohydrate. The in vivo responses correlated with in vitro digestibility assays. The data indicate that specific maize fiber preparations can reduce post-meal glucose excursions, while processed maize foods that lack fiber (e.g., some flaked cereals) have higher glycemic responses in other studies. Thus the metabolic impact of maize depends strongly on processing and fiber content.</p> </ul> <h4> People with compromised liver function or chronic hepatitis (relative risk if consuming contaminated maize) </h4> <ul> <li> 🧾 <li> Recommendation: Use caution with maize from unreliable sources; prefer tested/regulated grains and discuss diet with hepatology/primary care provider. <li> Reasoning: In people with existing liver disease, exposure to aflatoxins (when present in maize) may add carcinogenic and hepatotoxic risk and interact with disease progression. <li> Scientific_Study_Title: Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis <li> Scientific_Study_Authors: (Authors as listed on PubMed) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22405700/ <li> Scientific_Study_Excerpt: <p>This systematic review and meta-analysis combined epidemiologic studies and found a substantial population attributable fraction of hepatocellular carcinoma due to aflatoxin exposure, particularly in areas with chronic exposure and where hepatitis B virus infection is common. The paper quantified increased odds ratios for HCC associated with aflatoxin biomarkers and emphasized the compounded risk in HBV-positive populations. For individuals with pre-existing liver disease, this evidence supports minimizing dietary aflatoxin exposure, including from maize, as a precautionary measure.</p> </ul> <h4> Infants and breastfeeding mothers in high-exposure settings (risk of mycotoxin pass-through) </h4> <ul> <li> 🍼 <li> Recommendation: When local surveillance shows mycotoxin contamination of staple maize, breastfeeding mothers should seek alternative, tested food sources and public-health guidance; do not stop breastfeeding without medical advice. <li> Reasoning: Fumonisins and aflatoxins can be detected in human milk in some high-exposure settings, exposing infants who are particularly vulnerable to developmental and growth harm. <li> Scientific_Study_Title: Fumonisin B1 contamination in breast milk and its exposure in infants under 6 months of age in Rombo, Northern Tanzania <li> Scientific_Study_Authors: (Authors as listed on PubMed) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/25280923/ <li> Scientific_Study_Excerpt: <p>In this field study, nearly half of sampled breast milk specimens contained detectable fumonisin B1 at a range of concentrations; a proportion exceeded EU guidance levels for infants’ foods. Estimated infant exposures in some cases surpassed provisional tolerable daily intake benchmarks. The authors highlight carry-over of fumonisin from maternal diet into breast milk in communities consuming contaminated maize and recommend surveillance and mitigation strategies to protect infants.</p> </ul>

Heading

<h4> Food allergy / anaphylaxis (for sensitised persons)</h4> <ul> <li> ⚠️ <li> Side effect summary: In allergic individuals, eating even small amounts of maize can cause hives, swelling, breathing difficulty or full anaphylaxis. <li> Recommendation: Stop maize immediately if symptoms occur; seek urgent medical help for breathing or circulatory symptoms; consult an allergist for testing and management. <li> Reasoning: Immunologic sensitisation (IgE) to maize proteins causes rapid mast-cell mediated mediator release on re-exposure. <li> Severity Level: Severe <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Maize food allergy: a double-blind placebo-controlled study <li> Scientific_Study_Authors: J Scibilia, E A Pastorello, G Zisa, A Ottolenghi, B Ballmer-Weber, V Pravettoni, E Scovena, A Robino, C Ortolani <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/18778272/ <li> Scientific_Study_Excerpt: <p>The controlled challenge study showed that nearly 48% of selected patients with a clinical history of maize allergy had positive double-blind food challenges; some reacted at doses as low as 100 mg. Multi-system reactions occurred in a significant subset, fulfilling anaphylaxis criteria. The study provides direct clinical evidence of serious allergic risk in sensitised subjects and underlines the need for strict avoidance and emergency planning.</p> </ul> <h4> Mycotoxin-related toxicity (long-term: liver cancer, developmental defects) </h4> <ul> <li> ⚠️ <li> Side effect summary: Chronic ingestion of mycotoxin-contaminated maize can raise risk for liver cancer and, if exposure occurs in early pregnancy, for birth defects like neural tube defects. <li> Recommendation: Use regulated/tested maize; avoid visibly mouldy grain; public-health interventions and improved storage are essential where contamination is common. <li> Reasoning: Fumonisins and aflatoxins have documented biochemical toxicities (sphingolipid disruption; formation of DNA-adducts) linked to human disease in high-exposure settings. <li> Severity Level: Severe <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize <li> Scientific_Study_Authors: J Aone et al. (as listed on PubMed) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/15051815/ <li> Scientific_Study_Excerpt: <p>Experimental and epidemiologic lines of evidence show fumonisin B1 inhibits ceramide synthase, altering sphingolipid metabolism and interfering with folate receptor function in developing embryos. Mouse embryo culture and in vivo models produced neural tube and craniofacial defects after fumonisin exposure; human population data from maize-dependent regions show geographic correlations. Many adverse effects were preventable with folic acid supplementation in models, highlighting interaction between toxin exposure and maternal folate status.</p> </ul> <h4> Gastrointestinal discomfort when increasing maize fiber abruptly (bloating, gas) </h4> <ul> <li> 💨 <li> Side effect summary: New or high intake of soluble corn fiber or other maize fibers can cause mild to moderate bloating, gas or loose stools while the gut microbiota adapts. <li> Recommendation: Increase maize fiber gradually, drink adequate water, and reduce dose if symptoms are severe; consult a clinician if persistent. <li> Reasoning: Fermentation of nondigestible maize fibers by colonic bacteria produces gas and osmotic changes; clinical trials report tolerability with mild-moderate GI symptoms. <li> Severity Level: Mild <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Evaluation of the effect of four fibers on laxation, gastrointestinal tolerance and serum markers in healthy humans <li> Scientific_Study_Authors: (Authors listed on PubMed entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/20090313/ <li> Scientific_Study_Excerpt: <p>In a controlled human crossover study, subjects consumed 12 g/day of different fibers derived from maize or tapioca for 14 days. The test fibers were generally well tolerated but were associated with reports of mild to moderate GI symptoms in some participants (bloating, flatulence). Stool characteristics and fecal chemistry changed as expected with increased fermentation. Results indicate soluble corn fibers are safe for most people but may cause transient GI effects when use begins or doses are high.</p> </ul>

Heading

<h4> Cholesterol-lowering drugs (Statins; interaction with dietary phytosterols)</h4> <ul> <li> Interaction_Details: Corn and corn oil contain phytosterols that reduce intestinal cholesterol absorption; when consumed with statins the LDL-lowering effects can be additive (statin lowers synthesis, phytosterols lower absorption); ezetimibe reduces phytosterol absorption and therefore may modify this effect. <li> Severity: Mild <li> Recommendation: No need to avoid corn, but clinicians may consider the small additive LDL benefit when evaluating diet-drug plans; inform your clinician about high phytosterol food/supplement use. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/9555952/ <li> Scientific_Study_Title: Phytosterols partially explain differences in cholesterol metabolism caused by corn or olive oil feeding <li> Scientfic_Study_Authors: (Authors listed on PubMed entry) <li> Scientific_Study_Excerpt: <p>This human dietary trial compared corn oil (high in polyunsaturated fats and phytosterols) with olive oil and olive oil supplemented with phytosterols. Corn oil produced lower LDL-cholesterol than olive oil, and adding phytosterols to olive oil reproduced corn oil’s lipid effects. The study supports that phytosterols present in corn products reduce intestinal cholesterol absorption and contribute to differences in plasma lipids. The authors discuss implications for combined use of diet and lipid-lowering drugs, noting potential additive effects rather than harmful interactions.</p> </ul> <h4> Antidiabetic medications (e.g., sulfonylureas, insulin - interaction via maize fiber’s glucose-lowering effect)</h4> <ul> <li> Interaction_Details: Soluble corn fiber and maize formulations that slow carbohydrate absorption can reduce post-meal glucose; when combined with glucose-lowering drugs there is theoretical potential for additive glucose-lowering effects, especially with agents that cause hypoglycaemia. <li> Severity: Moderate <li> Recommendation: If you use antidiabetic medications, introduce high-dose maize fiber products gradually and monitor blood glucose closely; discuss any dietary supplement changes with your prescriber. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32235569/ <li> Scientific_Study_Title: The Role of Soluble Corn Fiber on Glycemic and Insulin Response <li> Scientfic_Study_Authors: (Authors listed on PubMed entry) <li> Scientific_Study_Excerpt: <p>Randomised crossover trials replacing part of digestible carbohydrate with soluble corn fiber demonstrated significantly lower postprandial glucose and insulin incremental responses compared with control treatments. The magnitude of the glucose-lowering effect depended on the formulation and matrix (beverage vs. solid food). Because these maize fiber products reduce post-meal glycaemia, there is biologic plausibility for additive glucose-lowering when combined with antidiabetic drugs; clinical monitoring is advised when introducing such fibers.</p> </ul> <h4> Oral drug formulations / drug release (corn-derived excipients) - example: modified release of venlafaxine with corn fiber excipient</h4> <ul> <li> Interaction_Details: Corn fiber gum and corn fiber derivatives are used as excipients in tablet formulations and can alter drug release kinetics (e.g., slow or extend release) when used in the formulation; this is relevant for pharmaceutical manufacturing rather than casual dietary co-use. <li> Severity: Mild <li> Recommendation: Patients taking medicines should not assume dietary corn alters prescription tablet formulation; however, manufacturers and formulators must account for corn-derived excipients. If you use maize-based medical foods or high-dose fiber supplements with narrow-therapeutic-index drugs, consult a pharmacist. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/37696343/ <li> Scientific_Study_Title: Extraction, physicochemical characterization, functionality, and excipient ability of corn fiber gum-starch isolate from corn milling industry waste <li> Scientfic_Study_Authors: (Authors listed on PubMed entry) <li> Scientific_Study_Excerpt: <p>This pharmaceutical-science study isolated a corn fiber gum-starch conjugate and evaluated it as an excipient in tablet formulations using venlafaxine hydrochloride as a model drug. Low concentrations allowed rapid drug release; higher concentrations extended release up to 12 hours, demonstrating that corn fiber derivatives can significantly modify tablet dissolution and release profiles. While this concerns formulation science rather than food co-administration, it shows corn components are capable of altering drug pharmacokinetics when used as ingredients in drug products.</p> </ul>